_{<legend id="taaff"></legend>}

瑞士羅姆來格公司

成立年份：1962

總資產(chǎn)（USD）：

員工總?cè)藬?shù)：200至249

主要競(jìng)爭(zhēng)優(yōu)勢(shì)：

業(yè)務(wù)類型：

年銷售額（USD）：

主要銷售市場(chǎng)：

業(yè)務(wù)類型：

主要產(chǎn)品類別：

所有產(chǎn)品：

簡(jiǎn)介

羅姆來格以“吹-灌-封”技術(shù)發(fā)明者的身份為您提供專業(yè)的支持并分享我們已經(jīng)實(shí)現(xiàn)的成千上萬(wàn)種柔性塑料包裝解決方案。目前在全球運(yùn)行的超過 1800 臺(tái) bottelpack 設(shè)備也代表了我們對(duì)液體/半固體產(chǎn)品進(jìn)行無菌灌裝的獨(dú)一無二的專業(yè)水平。累計(jì)生產(chǎn)超過數(shù)十億米長(zhǎng)的塑料薄膜所積累起來的知識(shí)和經(jīng)驗(yàn)也讓我們非常清楚如何加工塑料顆粒。

相關(guān)企業(yè)

蘇州海景醫(yī)藥科技有限公司

瑞士羅姆來格公司相關(guān)資訊

抗體結(jié)合定量的技術(shù)進(jìn)展與治療意義

輝瑞首款KAT6抑制劑乳腺癌臨床III期啟動(dòng)

2025年上半年，NMPA批準(zhǔn)創(chuàng)新藥盤點(diǎn)

諾華基因療法藥物OAV101擬納入優(yōu)先審評(píng)

「國(guó)藥系」要退出這家藥企

Toll樣受體的輔助分子及其功能

瑞士羅姆來格公司共有4個(gè)產(chǎn)品

EXTERNAL DESIGN

簡(jiǎn)介：Since the arrival of BFS technology, we have designed thousands of containers for filling volumes ranging from 0.04 ml to 10.000 ml, often in close cooperation with a customer. Many of our packaging solutions have set standards in the market for pharmaceu

YOU HAVE WISHES. WE HAVE THE PROCESSES.

簡(jiǎn)介：We don’t just advise our customers at the production stage – we also develop the best possible solutions with them beforehand. Our experts will give you detailed advice on what you need to know about product manufacture with BFS technology. An

TRIAL AND NO ERROR

簡(jiǎn)介：Injection solutions, inhalation solutions, infusion solutions, eye drops and gels, topical agents, oral agents, rinsing solutions, or contact lens cleaning agents – whatever it is you want us to fill, we will conduct trial filling to make

BFS MAKES SHORT WORK OF UNECONOMICAL PACKAGING SOLUTIONS

簡(jiǎn)介：With more than 50 systems in all sorts of configurations, Rommelag CMO runs one of the world’s most cutting-edge and largest bottelpack machine fleets. This allows us to perform quick and cost-optimized filling for you. Small-scale series, trial pha

CPHI制藥在線為您找到了瑞士羅姆來格公司共4 個(gè)產(chǎn)品，并有瑞士羅姆來格公司地址、瑞士羅姆來格公司電話、瑞士羅姆來格公司聯(lián)系人等信息，想要了解瑞士羅姆來格公司詳情盡在CPHI制藥在線。

推薦供應(yīng)商